Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2008 Apr 16;2008(2):CD005521.
doi: 10.1002/14651858.CD005521.pub2.

Systemic corticosteroids for acute gout

H J E M Janssens  1 , P L B J Lucassen, F A Van de Laar, M Janssen, E H Van de Lisdonk
Affiliations
Meta-Analysis

Systemic corticosteroids for acute gout

H J E M Janssens et al. Cochrane Database Syst Rev. .

Abstract

Background: Gout is one of the most frequently occurring rheumatic diseases, worldwide. Given the well-known drawbacks of the regular treatments for acute gout (non-steroidal anti-inflammatory drugs (NSAIDs), colchicine), systemic corticosteroids might be safe alternatives.

Objectives: To assess the efficacy and safety of systemic corticosteroids in the treatment of acute gout in comparison with placebo, NSAIDs, colchicine, other active drugs, other therapies, or no therapy.

Search strategy: Searches were done in the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007); MEDLINE (1966 to 2007) through PubMed; EMBASE (1974 to 2007); Web of Science (1975 to 2007); LILACS (1986 to 2007); and databases of ongoing trials (up to April 2007).

Selection criteria: Randomized controlled trials and controlled clinical trials investigating the use of systemic corticosteroids in the treatment of acute gout were included.

Data collection and analysis: Two review authors decided independently which trials to include. The same review authors also collected the data in a standardised form and assessed the methodological quality of the trial using validated criteria. When possible, continuous and dichotomous data were summarised statistically.

Main results: Three head to head trials involving 148 patients (74 systemic corticosteroids; 74 comparator drugs) were included. Placebo-controlled trials were not found. In the studies, different kinds of systemic corticosteroids and different kinds of control drugs were used, both administered in different routes. Intramuscular triamcinolone acetonide was compared respectively to oral indomethacine, and intramuscular adrenocorticotropic hormone (ACTH); oral prednisolone (together with a single intramuscular diclophenac injection) was compared to oral indomethacine (together with a single placebo injection). Outcome measurements varied: average number of days until total relief of signs, mean decrease of pain per unit of time in mm on a visual analogue scale (VAS) - during rest and activity. In the triamcinolone-indomethacine trial the clinical joint status was used as an additional outcome. Clinically relevant differences between the studied systemic corticosteroids and the comparator drugs were not found; important safety problems attributable to the used corticosteroids were not reported. The quality of the three studies was graded as very low to moderate. Statistical pooling of results was not possible.

Authors' conclusions: There is inconclusive evidence for the efficacy and effectiveness of systemic corticosteroids in the treatment of acute gout. Patients with gout did not report serious adverse effects from systemic corticosteroids, when used short term.

PubMed Disclaimer

Conflict of interest statement

All the authors declared no possible conflict of interest.

Update of

  • doi: 10.1002/14651858.CD005521

References

References to studies included in this review

Alloway 1993 {published data only}
    1. Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. The Journal of Rheumatology 1993;20(1):111‐3. [MEDLINE: ] - PubMed
Man 2007 {published data only}
    1. Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double‐blind, randomized, controlled trial. Annals of Emergency Medicine 2007;49:670‐7. [MEDLINE: ] - PMC - PubMed
Siegel 1994 {published data only}
    1. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. The Journal of Rheumatology 1994;21(7):1325‐7. [MEDLINE: ] - PubMed

References to studies excluded from this review

Axelrod 1988 {published data only}
    1. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis and Rheumatism 1988;31(6):803‐5. - PubMed
Conaghan 1994 {published data only}
    1. Conaghan PG, Day RO. Risks and benefits of drugs used in the management and prevention of gout. Drug Safety: an international journal of medical toxicology and drug experience 1994;11(4):252‐8. [MEDLINE: ] - PubMed
Groff 1990 {published data only}
    1. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Seminars in Arthritis and Rheumatism 1990;19(6):329‐36. [MEDLINE: ] - PubMed
Werlen 1996 {published data only}
    1. Werlen D, Gabay C, Vischer TL. Corticosteroid therapy for the treatment of acute attacks of crystal‐induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Revue du rhumatisme (English edition ) 1996;63(4):248‐54. [MEDLINE: ] - PubMed

References to ongoing studies

ISRCTN14648181 {published data only}
    1. Lisdonk E. Randomised double blind trial of prednisone and naproxen in treatment of crystal proven acute gout. http://www.controlled‐trials.com/ISRCTN14648181/14648181 2005.

Additional references

Abbott 1988
    1. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. Journal of Clinical Epidemiology 1988;41:237‐42. - PubMed
Ahern 1987
    1. Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Australian and New Zealand Journal of Medicine 1987;17(3):301‐4. [MEDLINE: ] - PubMed
Altman 1988
    1. Altman RD, Honig S LJ, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. The Journal of Rheumatology 1988;15:1422‐6. [MEDLINE: ] - PubMed
Arnold 1988
    1. Arnold MH, Preston SJ, Watson Buchanan W. Comparison of the natural history of untreated acute gouty arthritis vs acute arthritis treated with non‐steroidal‐anti‐inflammatory drugs. British Journal of Clinical Pharmacology 1988;26:488‐9. [MEDLINE: ] - PMC - PubMed
Arromdee 2002
    1. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising?. The Journal of Rheumatology 2002;29(11):2403‐6. [MEDLINE: ] - PubMed
Bellamy 1987
    1. Bellamy N, Downie WW, Buchanan WW. Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non‐steroidal anti‐inflammatory drugs. British Journal of Clinical Pharmacology 1987;24:33‐6. [MEDLINE: ] - PMC - PubMed
Bieber 2004
    1. Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis and Rheumatism 2004;50(8):2400‐14. [MEDLINE: ] - PubMed
Cates 2003 [Computer program]
    1. Chris Cates www.nntonline.com. Visual Rx ‐ NNT Calculator. Chris Cates www.nntonline.com, 2003.
Cohen 1960
    1. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. [Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. Cohen 1960 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46.]
Fam 1998
    1. Fam AG. Gout in the elderly. Clinical presentation and treatment. Drugs & Aging 1998;13(3):229‐43. [MEDLINE: ] - PubMed
Gotzsche 2005
    1. Gotzsche PC, Johansen HK. Short‐term low‐dose corticosteroids vs placebo and nonsteroidal anti‐inflammatory drugs in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD000189.pub2; MEDLINE: ] - DOI - PMC - PubMed
Higgins 2002
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58. - PubMed
Higgins 2005
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.org/resources/handbook/hbook.htm. Chichester, UK: John Wiley & Sons, Ltd, (accessed 30 August 2005).
Janssens 2003
    1. Janssens HJEM, Lisdonk EH, Bor H, Hoogen HJM, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Family Practice 2003;20:413‐6. - PubMed
Janssens 2006
    1. Janssens HJEM, Lisdonk EH, Janssen M, Hoogen HJM, Verbeek ALM. Gout, not induced by diuretics? A case‐control study from primary care. Annals of the Rheumatic Diseases 2006;65:1080‐3. - PMC - PubMed
Jones 1996
    1. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36‐9. [MEDLINE: ] - PMC - PubMed
Kearney 2006
    1. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo‐oxygenase‐2 inhibitors and traditional non‐steroidal anti‐inflammatory drugs increase the risk of atherothrombosis? Meta‐analysis of randomised trials. BMJ 2006;332:1302‐8. [MEDLINE: ] - PMC - PubMed
Kim 2003
    1. Kim KY, Schumacher HR, Hunsche E, Wertheimer AI KS. A literature review of the epidemiology and treatment of acute gout. Clinical Therapeutics 2003;25(6):1593‐617. [MEDLINE: ] - PubMed
Krishnan 2006
    1. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis and Rheumatism 2006;54(8):2688‐96. [MEDLINE: ] - PubMed
Lewis 2002
    1. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose‐response relationships between individual nonaspirin nonsteroidal anti‐inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta‐analysis based on individual patient data. British Journal of Clinical Pharmacology 2002;54:320‐6. [MEDLINE: ] - PMC - PubMed
Maccagno 1991
    1. Maccagno A, Giorgio E, Romanowicz A. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. Current Medical Research and Opinion 1991;12(7):423‐9. [MEDLINE: ] - PubMed
Morris 2003
    1. Morris I, Varughese G, Mattingly P. Colchicine in acute gout. BMJ 2003;327(7426):1275‐6. [MEDLINE: ] - PMC - PubMed
Perez‐Ruiz 2000
    1. Perez‐Ruiz F, Calabozo M, Herrero‐Beites AM, Garcia‐Erauskin G, Pijoan JI. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 2000;86(3):287‐91. [MEDLINE: ] - PubMed
Petersel 2007
    1. Petersel D, Schlesinger N. Treatment of acute gout in hospitalized patients. The Journal of Rheumatology 2007;34(7):1566‐8. - PubMed
Robinson 2002
    1. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 2002;31(1):150‐3. [MEDLINE: ] - PubMed
Rowe 2001
    1. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002178%C2%A0; MEDLINE: ] - DOI - PubMed
Rubin 2004
    1. Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis and Rheumatism 2004;50(2):598‐606. [MEDLINE: ] - PubMed
Schlesinger 2004
    1. Schlesinger N. Management of acute and chronic gouty arthritis: present state‐of‐the‐art. Drugs 2004;64(21):2399‐416. [MEDLINE: ] - PubMed
Schlesinger 2006
    1. Schlesinger N, Schumacher HR, Catton M, Maxwell L. Colchicine for acute gout. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006190; MEDLINE: ] - DOI - PubMed
Schumacher 1996
    1. Schumacher HR. Crystal‐induced arthritis: an overview. The American Journal of Medicine 1996;100(2A):46S‐52S. [MEDLINE: ] - PubMed
Schumacher 2002
    1. Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324(7352):1488‐92. [MEDLINE: ] - PMC - PubMed
Schumacher 2005
    1. Schumacher HR Jr, Edwards LN P‐RF, Becker M, Chen LX, Furst DE, Joseph‐Ridge N, et al. Outcome measures for acute and chronic gout. The Journal of Rheumatology 2005;32:2452‐5. [MEDLINE: ] - PubMed
Shrestha 1995
    1. Shrestha M, Morgan DL, Moreden JM, Singh R, Nelson M, Hayes JE. Randomized double‐blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Annals of Emergency Medicine 1995;26(6):682‐6. [MEDLINE: ] - PubMed
Sturge 1977
    1. Sturge RA, Scott JT, Hamilton EB, Liyanage SP, Dixon AS, Davies J, Engler C. Multicentre trial of naproxen and phenylbutazone in acute gout. Annals of the Rheumatic Diseases 1977;36(1):80‐2. [MEDLINE: ] - PMC - PubMed
Sutaria 2006
    1. Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout ‐ a systematic review. Rheumatology (Oxford) 2006;45:1422‐31. [MEDLINE: ] - PubMed
Terkeltaub 2003
    1. Terkeltaub RA. Clinical practice. Gout. New England Journal of Medicine 2003;349(17):1647‐55. [MEDLINE: ] - PubMed
Tugwell 2004
    1. Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, et al. Evidence Based Rheumatology. BMJ Books, 2004.
Underwood 2006
    1. Underwood M. Diagnosis and management of gout. BMJ 2006;332:1315‐9. [MEDLINE: ] - PMC - PubMed
Van de Lisdonk 2003
    1. Lisdonk EH, Bosch WJHM, Huygen FJA, Lagro‐Janssen ALM. Diseases in general practice. Ziekten in de Huisartspraktijk. 4th Edition. Maarssen: Elsevier, 2003.
Van der Linden 2004
    1. Linden MW, Wetsert GP, Bakker DH, Schellevis FG. Illness and disease in the community and family practice [Klachten en aandoeningen in de bevolking en in de huisartspraktijk]. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht, Bilthoven: NIVEL, Rijksinstituut voor Volksgezondheid en Milieu, 2004 (available from: http://www.nivel.nl/pdf/ns2_rapport1.pdf). [MEDLINE: ; http://www.nivel.nl/pdf/ns2_rapport1.pdf]
Wallace 1977
    1. Wallace SL, Robbinson H, Masi AT, Decker JL, McArty DJ, Yü T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis and Rheumatism 1977;20(3):895‐900. - PubMed
Wise 1996
    1. Wise CM, Agudelo CA. Gouty arthritis and uric acid metabolism. Current Opinion in Rheumatology 1996;8(3):248‐54. [MEDLINE: ] - PubMed

MeSH terms